ABD Dermatology Practice Questions - American Board Of Dermatology Certification Examination (CORE) Exam

Access More Questions

Which of the following biologics targets the p19 subunit of interleukin-23 and is approved for moderate-to-severe plaque psoriasis?

Secukinumab Risankizumab Adalimumab Ustekinumab

Correct Answer:

Risankizumab

Access more questions from this quiz

Continue to ABD Dermatology Practice Questions - American Board of Dermatology Certification Examination (CORE) Exam for more practice questions and the full quiz experience.

Access More Questions